Exosomes: Emerging biomarkers and targets for ovarian cancer

Maggie K S Tang1, Alice S T Wong1

  • 1School of Biological Sciences, University of Hong Kong, Pokfulam Road, Hong Kong.

Cancer Letters
|July 21, 2015
PubMed

Insights

Tumor microenvironment interactions, mediated by exosomes, are crucial for cancer progression. Exosome research offers potential for ovarian cancer diagnosis, prognosis, and treatment strategies.

Area of Science:

  • Oncology
  • Cell Biology
  • Biochemistry

Background:

  • Current chemotherapies face limitations, driving the search for novel cancer treatments.
  • Tumor progression is increasingly understood to be driven by interactions within the tumor microenvironment, rather than tumor cells alone.
  • Exosomes, small extracellular vesicles, are key mediators of intercellular communication within this microenvironment.

Purpose of the Study:

  • To highlight the emerging role of exosomes in cancer progression.
  • To focus on the specific relevance of exosomes in ovarian cancer due to its metastatic patterns.
  • To discuss the potential clinical applications of exosome research in diagnosis, prognosis, and treatment.

Main Methods:

  • This review synthesizes existing scientific literature on exosomes and their role in cancer.
  • It specifically examines studies related to ovarian cancer and exosome-mediated communication.
  • The review analyzes the mechanisms of exosome intercellular communication via paracrine signaling.

Main Results:

  • Exosomes facilitate communication between tumor cells and various microenvironment components, including fibroblasts, endothelial cells, and immune cells.
  • These vesicles also interact with noncellular extracellular matrices, influencing the tumor microenvironment.
  • The unique metastatic route of ovarian cancer makes it a pertinent model for studying exosome functions.

Conclusions:

  • Exosomes are critical players in tumor microenvironment dynamics and cancer progression.
  • Understanding exosome-mediated communication is vital for developing targeted cancer therapies.
  • Exosome research holds significant promise for advancing clinical applications in ovarian cancer diagnosis, prognosis, and treatment.